This application is submitted in order for the University of Florida, Department of Statistics with assistance from the Department of Health Policy and Epidemiology, to continue its role of Statistical Office, Pediatric Oncology Group (POG). In this role, we plan to collaborate with our clinical colleagues and clinical research associates (CRAs) at the POG institutions in protocol development, clinical trial design, correlative laboratory studies, data management, safety monitoring, quality assurance, and publication of results. Our objectives for the next five years include (a) to expand protocol coverage to accrue 2800 therapeutic patients per year by 1996; (b)to provide remote data entry by POG institutions by January, 1997; (c) to continue to provide improved groupwide communication via the POG Electronic Bulletin Board System (BBS); (d) to continue to work toward pragmatic minimal data requirements, to ensure efficient operation; (e) to continue to contribute to statistical methods relevant to pediatrics trials; (f) to collaborate with the Children's Cancer Group (CCG) on intergroup studies where POG patient resources are insufficient on their own; and (g) develop electronic storage for filing protocols, correspondence, and patient records to reduce our paper load. The major emphasis of our research is to conduct randomized Phase III trials aimed at improving the cure rates for children, and to identify children at especially high risk for failure. By the use of Phase I, Phase II, and Pilot studies, new therapeutic strategies can be assessed for possible inclusion in later Phase In trials. Statistical Office design, monitoring, and analysis play an integral part of the process. The Statistical office, clinical study coordinators, and Operations Office work closely together, along with the Clinical Trials Monitoring Branch, to assess compliance and institutional performance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA029139-20
Application #
6137396
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Program Officer
Smith, Malcolm M
Project Start
1980-12-01
Project End
2002-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
20
Fiscal Year
2000
Total Cost
$2,178,488
Indirect Cost
Name
University of Florida
Department
Biostatistics & Other Math Sci
Type
Schools of Arts and Sciences
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
DuBois, Steven G; Mody, Rajen; Naranjo, Arlene et al. (2017) MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Pediatr Blood Cancer 64:
von Allmen, Daniel; Davidoff, Andrew M; London, Wendy B et al. (2017) Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma. J Clin Oncol 35:208-216
Sankaran, Hari; Danysh, Heather E; Scheurer, Michael E et al. (2016) The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer 63:1557-62
Lupo, Philip J; Danysh, Heather E; Plon, Sharon E et al. (2015) Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database. Cancer Med 4:781-90
Mansour, Marc R; Abraham, Brian J; Anders, Lars et al. (2014) Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346:1373-7
Schultz, K R; Devidas, M; Bowman, W P et al. (2014) Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031. Leukemia 28:964-7
Lupo, Philip J; Zhou, Renke; Skapek, Stephen X et al. (2014) Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Int J Cancer 134:431-6
Schultz, K R; Carroll, A; Heerema, N A et al. (2014) Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031. Leukemia 28:1467-71
Lupo, Philip J; Danysh, Heather E; Skapek, Stephen X et al. (2014) Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Cancer Causes Control 25:905-13
Grufferman, Seymour; Lupo, Philip J; Vogel, Rachel Isaksson et al. (2014) Parental military service, agent orange exposure, and the risk of rhabdomyosarcoma in offspring. J Pediatr 165:1216-21

Showing the most recent 10 out of 268 publications